Breye Therapeutics
breye.com
Healthcare
Breye Therapeutics develops treatments for retinal diseases, focusing on non-proliferative diabetic retinopathy and age-related macular degeneration. The company aims to provide oral alternatives to existing therapies.
Founded
2019
Total Funding
Tens of millions
Total Rounds
1
First Raise
Oct 2, 2026
Latest Raise
Oct 2, 2026
Get notified when Breye Therapeutics and companies like it raise
New funding rounds in your inbox every week 路 No noise, all Signal.
This company may have changed its name or domain. Shared founders detected on: breyetx.com
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
Open Roles
Loading open roles...
All Funding Rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 10/2/2026 | |||
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics
Breye Therapeutics 路 Never miss the next round
Who's raising next?
New funding rounds in your inbox every week 路 Free